Inspiratory Muscle Training on The Severity of Exercise-Induced Bronchoconstriction and Time-Trial Performance (IMT_EIB)

Inclusion Criteria: * Male and female, between the ages of 18 to 35 years. * Required to be a competitive recreational or college athlete and have at least 1-2 years of cycling or biking experience. * Body Mass Index (BMI) of 18.5 to 28 kg/m\^2 * Considered "moderately to highly active" by the International Physical Activity Questionnaire (IPAQ). * Have clinically treated mild to moderate persistent asthma and/or exercise-induced bronchoconstriction (EIB), with a resting forced expiratory volume in 1 second (FEV1) \> 65% of predicted. * A ≥ 10% drop in FEV1 after eucapnic voluntary hyperpnea (EVH). * Prescribed short-acting β2-agonists (SABAs) by a physician. * Comfortable not taking SABA before experimental visits. Exclusion Criteria: * History of smoking or recreational smoking, cardiovascular disease, renal disease, neurological disease, and metabolic disease. * Currently taking asthma maintenance medications (e.g., corticosteroids and leukotriene modifiers) * Any injuries in the past 6 months. * Taking selective serotonin reuptake inhibitors (SSRI)'s (antidepressants and anxiety medication), attention-deficit hyperactivity disorder (ADHD) medication, and chronically consume pain medication (Aleve, Tylenol, cannabidiol (CBD), etc.). * Has had or is positive for COVID-19. * Resting blood pressure of \> 130 mmHg systolic or 90 mmHg diastolic. * Resting Pulse rate of \> 100 bpm. * Regularly consuming fish oil supplements or eating more then one fish meal per week